Pathway analysis of altered gene expression levels revealed strong effects of Nurr1 silencing on genes involved in PD and AD, oxidative phosphorylation, apoptosis, and p53 signaling (Figure 3g). This evidence concerns the gene TP53 and Parkinson disease.